The Nordic AML Meeting 2026 held on Sep 16 -18th 2026 in Bergen, brought together researchers and clinicians from across the Nordic countries to discuss recent advances in acute myeloid leukemia (AML) caring and research, with a particular focus on TP53-mutated disease and FLT3-targeted therapies. The challenge of treating TP53-mutated AML, one of the highest-risk READ MORE
Nordic AML Meeting – Bergen September 16-18, 2026
We are delighted to invite you to the upcoming Nordic AML meeting, taking place in Bergen – September 16-18, 2026. Join us not only for an inspiring scientific program filled with cutting-edge insights and special focuses on TP53 and FLT3, but also for the Educational Day for physicians in the Nordics who take care of READ MORE
Beyond Academia: Careers in Biotech, Pharma & Clinical Research
Time: 20th Aug 2026. 14:00 – 17:00. Place: Eitri. Haukelandsbakken 31. Join our Career Seminar to meet and hear about personal career stories from start-ups, biotech companies, CROs, as well as the pharmaceutical industry and CONNECT. Confirmed speakers include: Knut Martin Torgersen (CONNECT), Terje Kolstad (Johnson & Johnson), Ann Kari Grindheim (Pluvia), Satwinder Singh (Mendus), READ MORE
Oriol Castells and Stein-Erik Gullaksen at the Meet-the-Expert (MTE) – EHA2026 Congress in Stockholm
Congratulations to Oriol Castells and Stein-Erik Gullaksen for their excellent cutting-edge research work presented at EHA2026 Congress in Stockholm (June 11–14, 2026). Both were chosen to be among the experts at the Meet-the-Expert sections at the congress. “Mapping CSF1R Singaling in AML – a Functional Approach” Health Talk “Can We Predict Response in CML after READ MORE
